NVAX Jan 2026 4.000 call
OPR - OPR Delayed Price. Currency in USD
Add to watchlist
As of 10:52AM EDT. Market open.
| Previous Close | 8.50 |
| Open | 7.68 |
| Bid | 0.00 |
| Ask | 0.00 |
| Strike | 4.00 |
| Expire Date | 2026-01-16 |
| Day's Range | 7.68 - 8.50 |
| Contract Range | N/A |
| Volume | |
| Open Interest | N/A |
Yahoo Finance UKTrending tickers: Anglo American, GameStop, Vodafone, Greggs and Novavax
The latest investor updates on stocks that are trending on Tuesday.
PR NewswireNovavax to Participate in BofA Securities 2024 Health Care Conference
Novavax, Inc. (Nasdaq: NVAX), a global company advancing protein-based vaccines with its Matrix-M™ adjuvant, today announced it will participate in the BofA Securities 2024 Health Care Conference.
ZacksNovavax (NVAX) Q1 Earnings Miss, Stock Soars on Sanofi Deal
Novavax (NVAX) partners with Sanofi to market its COVID-19 vaccine and also develop novel COVID-19-influenza combination vaccines. This announcement even overshadows the dismal Q1 results.
© 2024 Yahoo. All rights reserved.